News & Training
Staburo news about trainings, events and more
Staburo at the B2RUN Munich
Staburo showed that its employees do not only possess mental, but as well physical fitness. The Staburo team did not let itself be put off by the changing weather (statistically it should have rained) and took part in the B2RUN corporate challenge race 2016 in Munich....
2016 PSI Conference
Staburo took part in the 2016 PSI Conference „Promoting Statistical Insight and Collaboration in Drug Development“ that took place in Berlin between 22 and 25 May. The conference featured a wide range of interesting topics for statisticians in the pharmaceutical and...
Career Day at MPI
Staburo took part in the second Career Day at the Max-Planck-Institute of Psychiatry on 11 May 2016 in Munich. Josef Höfler and Roland Stieger gave a short overview of Staburo services and insights into the work of biostatisticians and statistical programmers in...
The Staburo team is growing
We are very pleased to welcome Dr. Gabriele Bleckert in our team. Gabriele Bleckert will support our customers with her experience in the areas of statistical programming and biostatistics. We are looking forward to a great cooperation!
NEW Staburo homepage
We have completely redesigned the Staburo homepage to better inform you about our services. The simplified navigation enables you to find your desired services faster, and with the modern design, reading the website on your smartphone or tablet has been improved. In...
Network meta-analyses
Network meta-analyses (NMAs) are a methods, which allows indirect comparisons of several medications. Indirect comparisons play an important role in the assessment of the cost-benefit ratio of drugs. This talk starts with important basic concepts in the field of...
Biomarker in clinical development
Biomarker play an important role in modern pharmaceutical development because they allow a treatment adjusted for the patient’s individual circumstances. Recommendation for specific therapies for example based on the patient’s very own gene mutation profile (keyword...
Response criteria in oncology
In clinical trials, a treatment’s efficiency and safety is measured and evaluated. In oncology, standards have been developed to enable the harmonization of study results. These criteria are used for efficiency (response of treatment) as well as for safety (e.g. to...
You need support in data science?
Memberships and awards
